Thus, molecular markers of CAFs, such as fibroblast activation protein (FAP), C-X-C motif chemokine ligand 12 (CXCL12), and hepatocyte growth factor (HGF) are emerging as selective therapeutic targets in the cancer stroma [4]. This evidence concerns the gene HGF and cancer.